As the new National Policy & Advocacy Director in Oncology at Janssen Matthew’s is an avid cyclist. When he learned about Janssen’s commitment to Road to Victories he signed up almost immediately. His work and passion for cycling make him a great team member. This will be a great introduction to the MMRF and most importantly, he will have the chance to spend a week with multiple myeloma patients and their caregivers. He looks forward to the connections and relationships that will form.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.About Janssen Oncology
Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.Learn More